NCT03893838

Brief Summary

Refractive surgeries can be divided into two distinct categories: 1) corneal surgeries (superficial and deep procedures) carried on the surface of the eye and 2) lens surgeries (phakic IOL, refractive lens exchange) - an intraocular intervention, performed in the anterior or posterior chamber or on the lens. In the proposed protocol focus is on the corneal refractive surgeries impact on monochromatic higher-order aberrations on the one hand and chromatic aberrations on the other. During the surgery in order to get the patient emmetropic, refractive surgery corrects optical defects by decreasing aberrations of lower orders ) simultaneously increases high-order aberrations (that is perceived by the patient as halo, glare or starburst). Informations about prevalence and causes of higher order aberrations after refractive surgery are numerous but there is no information about chromatic aberrations.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 25, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 28, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

March 29, 2022

Status Verified

March 1, 2022

Enrollment Period

3 years

First QC Date

March 25, 2019

Last Update Submit

March 27, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • number of high order and chromatic aberrations after refractive surgery

    number of high order and chromatic aberrations after refractive surgery

    6 months

  • Chromoretinoscopy for near (MEM) and distance

    Conducted with a modified by researchers retinoscopy with distinct filters

    6 months

  • Aberrometry reading for corneal HOA

    Conducted with aberrometer and corneal tomography

    6 months

  • Transverse chromatic aberration

    Conducted with a modified by researchers aniseikonia test (with red and green lenses)

    6 months

Secondary Outcomes (3)

  • Change in Hue 100 test

    6 months

  • Change of contrast sensitivity for near vision

    6 months

  • Visual Function Questionaire 25

    6 months

Study Arms (3)

Post refractive surgery without HOA

Patients post refractive surgery that do not complain on the high order aberrations such as glare, halo and starburst.

Post refractive surgery with HOA

Patients post refractive surgery that do complain on the high order aberrations such as glare, halo and starburst.

Post refractive surgery with rainbow HOA

Patients post refractive surgery that do complain on: 1. the high order aberrations such as glare, halo and starburst but with the chromatic aureola 2. difficulties working with LCD projectors, monitors, cell phones and tablets

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients after refractive surgery

You may qualify if:

  • patient after corneal refractive surgery at least for 4 months
  • post surgical refraction within +/- 0.75 diopter of spherical and +/- 1.0 diopter of cylindrical error
  • willing and able to understand and sign an informed consent form.

You may not qualify if:

  • patient unable to participate in the study
  • any corneal diseases, eyes trauma or systemic diseases history; keratoconus or tendency of keratoconus
  • corneal macula and obvious pannus; current enrolment in another clinical trial/research project

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Optics and Photonics

Wroclaw, 50-370, Poland

Location

MeSH Terms

Conditions

Refractive ErrorsCorneal Wavefront Aberration

Condition Hierarchy (Ancestors)

Eye DiseasesCorneal Diseases

Study Officials

  • Joanna Przeździecka-Dołyk, PhD

    Wrocław University of Science and Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
24 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2019

First Posted

March 28, 2019

Study Start

February 1, 2019

Primary Completion

February 1, 2022

Study Completion

February 1, 2024

Last Updated

March 29, 2022

Record last verified: 2022-03

Locations